• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

左半胰切除术胰瘘预测模型的国际多中心验证以及联合DISPAIR-FRS预测模型的开发与验证。

International multicentre validation of the left pancreatectomy pancreatic fistula prediction models and development and validation of the combined DISPAIR-FRS prediction model.

作者信息

Bonsdorff Akseli, Kjeseth Trond, Kirkegård Jakob, de Ponthaud Charles, Ghorbani Poya, Wennerblom Johanna, Williamson Caroline, Acher Alexandra W, Thillai Manoj, Tarvainen Timo, Helanterä Ilkka, Uutela Aki, Sirén Jukka, Kokkola Arto, Sahakyan Mushegh, Kleive Dyre, Hagen Rolf, Lund Andrea, Nielsen Mette F, Vaillant Jean-Christophe, Fristedt Richard, Biörserud Christina, Bratlie Svein O, Tingstedt Bobby, Labori Knut J, Gaujoux Sébastien, Wigmore Stephen J, Hallet Julie, Sparrelid Ernesto, Sallinen Ville

机构信息

Department of Gastroenterological Surgery, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.

Department of Hepato-Pancreato-Biliary Surgery, Rikshospitalet, Oslo University Hospital, Oslo, Norway.

出版信息

Br J Surg. 2025 Mar 4;112(3). doi: 10.1093/bjs/znae313.

DOI:10.1093/bjs/znae313
PMID:40114539
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11926329/
Abstract

BACKGROUND

Every fifth patient undergoing left pancreatectomy develops a postoperative pancreatic fistula (POPF). Accurate POPF risk prediction could help. Two independent preoperative prediction models have been developed and externally validated: DISPAIR and D-FRS. The aim of this study was to validate, compare, and possibly update the models.

METHODS

Patients from nine high-volume pancreatic surgery centres (8 in Europe and 1 in North America) were included in this retrospective cohort study. Inclusion criteria were age over 18 years and open or minimally invasive left pancreatectomy since 2010. Model performance was assessed with discrimination (receiver operating characteristic (ROC) curves) and calibration (calibration plots). The updated model was developed with logistic regression and internally-externally validated.

RESULTS

Of 2284 patients included, 497 (21.8%) developed POPF. Both DISPAIR (area under the ROC curve (AUC) 0.62) and D-FRS (AUC 0.62) performed suboptimally, both in the pooled validation cohort combining every centre's data and centre-wise. An updated model, named DISPAIR-FRS, was constructed by combining the most stable predictors from the existing models and incorporating other readily available patient demographics, such as age, sex, transection site, pancreatic thickness at the transection site, and main pancreatic duct diameter at the transection site. Internal-external validation demonstrated an AUC of 0.72, a calibration slope of 0.93, and an intercept of -0.02 for the updated model.

CONCLUSION

The combined updated model of DISPAIR and D-FRS named DISPAIR-FRS demonstrated better performance and can be accessed at www.tinyurl.com/the-dispair-frs.

摘要

背景

每五名接受左半胰切除术的患者中就有一名会发生术后胰瘘(POPF)。准确的POPF风险预测可能会有所帮助。已经开发并进行了外部验证的两种独立术前预测模型:DISPAIR和D-FRS。本研究的目的是验证、比较并可能更新这些模型。

方法

本回顾性队列研究纳入了来自九个高容量胰腺手术中心(欧洲8个,北美1个)的患者。纳入标准为年龄超过18岁且自2010年以来接受开放或微创左半胰切除术。通过区分度(受试者操作特征(ROC)曲线)和校准(校准图)评估模型性能。使用逻辑回归开发更新模型并进行内部-外部验证。

结果

在纳入的2284例患者中,497例(21.8%)发生了POPF。DISPAIR(ROC曲线下面积(AUC)为0.62)和D-FRS(AUC为0.62)在合并每个中心数据的汇总验证队列以及按中心分析时表现均欠佳。通过结合现有模型中最稳定的预测因素并纳入其他易于获取的患者人口统计学信息,如年龄、性别、横断部位、横断部位的胰腺厚度以及横断部位的主胰管直径,构建了一个名为DISPAIR-FRS的更新模型。内部-外部验证显示更新模型的AUC为0.72,校准斜率为0.93,截距为-0.02。

结论

名为DISPAIR-FRS的DISPAIR和D-FRS联合更新模型表现更佳,可在www.tinyurl.com/the-dispair-frs上获取。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1603/11926329/a3ada83a72dc/znae313f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1603/11926329/42912b3512f1/znae313f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1603/11926329/bcf717868754/znae313f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1603/11926329/a3ada83a72dc/znae313f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1603/11926329/42912b3512f1/znae313f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1603/11926329/bcf717868754/znae313f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1603/11926329/a3ada83a72dc/znae313f3.jpg

相似文献

1
International multicentre validation of the left pancreatectomy pancreatic fistula prediction models and development and validation of the combined DISPAIR-FRS prediction model.左半胰切除术胰瘘预测模型的国际多中心验证以及联合DISPAIR-FRS预测模型的开发与验证。
Br J Surg. 2025 Mar 4;112(3). doi: 10.1093/bjs/znae313.
2
Comparing the distal pancreatectomy fistula risk score (D-FRS) and DISPAIR-FRS for predicting pancreatic fistula after distal pancreatectomy.比较远端胰腺切除术吻合口漏风险评分(D-FRS)和 DISPAIR-FRS 预测远端胰腺切除术后胰瘘的风险。
ANZ J Surg. 2024 Apr;94(4):667-673. doi: 10.1111/ans.18819. Epub 2023 Dec 7.
3
Predicting pancreatic fistula after central pancreatectomy using current fistula risk scores for pancreaticoduodenectomy and distal pancreatectomy.利用胰十二指肠切除术和胰尾部切除术的现有瘘风险评分预测胰体尾切除术后的胰瘘。
Pancreatology. 2023 Nov;23(7):843-851. doi: 10.1016/j.pan.2023.09.079. Epub 2023 Sep 11.
4
Development and external validation of DISPAIR fistula risk score for clinically relevant postoperative pancreatic fistula risk after distal pancreatectomy.发展和外部验证 DISPAIR 瘘管风险评分用于预测远端胰腺切除术后临床相关术后胰瘘风险。
Br J Surg. 2022 Oct 14;109(11):1131-1139. doi: 10.1093/bjs/znac266.
5
Distal Pancreatectomy Fistula Risk Score (D-FRS): Development and International Validation.远端胰腺切除术瘘风险评分 (D-FRS):制定与国际验证。
Ann Surg. 2023 May 1;277(5):e1099-e1105. doi: 10.1097/SLA.0000000000005497. Epub 2022 Jul 7.
6
External validation of fistula risk scores for postoperative pancreatic fistula after distal pancreatectomy.远端胰腺切除术后胰瘘术后瘘风险评分的外部验证。
Surgery. 2023 Dec;174(6):1416-1421. doi: 10.1016/j.surg.2023.09.007. Epub 2023 Oct 10.
7
AutoFRS: an externally validated, annotation-free approach to computational preoperative complication risk stratification in pancreatic surgery - an experimental study.自动FRS:一种经外部验证的、无需注释的胰腺手术术前计算并发症风险分层方法——一项实验研究
Int J Surg. 2025 May 1;111(5):3212-3223. doi: 10.1097/JS9.0000000000002327.
8
Nationwide validation of the distal fistula risk score (D-FRS).全国范围内验证远瘘风险评分(D-FRS)。
Langenbecks Arch Surg. 2023 Dec 20;409(1):14. doi: 10.1007/s00423-023-03192-w.
9
Updated Alternative Fistula Risk Score (ua-FRS) to Include Minimally Invasive Pancreatoduodenectomy: Pan-European Validation.更新后的替代瘘管风险评分 (ua-FRS) 纳入了微创胰十二指肠切除术:泛欧验证。
Ann Surg. 2021 Feb 1;273(2):334-340. doi: 10.1097/SLA.0000000000003234.
10
Analysis of factors influencing pancreatic fistula after minimally invasive pancreaticoduodenectomy and establishment of a new prediction model for clinically relevant pancreatic fistula.微创胰十二指肠切除术后胰瘘影响因素分析及临床相关胰瘘新预测模型的建立。
Surg Endosc. 2024 May;38(5):2622-2631. doi: 10.1007/s00464-024-10770-6. Epub 2024 Mar 18.

本文引用的文献

1
Interobserver Variability in the International Study Group for Pancreatic Surgery (ISGPS)-Defined Complications After Pancreatoduodenectomy: An International Cross-Sectional Multicenter Study.胰十二指肠切除术后国际胰腺外科研讨组(ISGPS)定义的并发症的观察者间变异性:一项国际横断面多中心研究。
Ann Surg. 2024 Nov 1;280(5):728-733. doi: 10.1097/SLA.0000000000006473. Epub 2024 Aug 1.
2
Standardizing definitions and terminology of left-sided pancreatic resections through an international Delphi consensus.通过国际德尔菲共识规范左侧胰腺切除术的定义和术语。
Br J Surg. 2024 Apr 3;111(4). doi: 10.1093/bjs/znae039.
3
Prophylactic abdominal drainage after distal pancreatectomy (PANDORINA): an international, multicentre, open-label, randomised controlled, non-inferiority trial.
预防性腹部引流在胰体尾切除术后(PANDORINA):一项国际性、多中心、开放性标签、随机对照、非劣效性临床试验。
Lancet Gastroenterol Hepatol. 2024 May;9(5):438-447. doi: 10.1016/S2468-1253(24)00037-2. Epub 2024 Mar 16.
4
Evaluation of clinical prediction models (part 2): how to undertake an external validation study.临床预测模型的评估(第 2 部分):如何进行外部验证研究。
BMJ. 2024 Jan 15;384:e074820. doi: 10.1136/bmj-2023-074820.
5
Evaluation of clinical prediction models (part 1): from development to external validation.临床预测模型的评估(第 1 部分):从建立到外部验证。
BMJ. 2024 Jan 8;384:e074819. doi: 10.1136/bmj-2023-074819.
6
Nationwide validation of the distal fistula risk score (D-FRS).全国范围内验证远瘘风险评分(D-FRS)。
Langenbecks Arch Surg. 2023 Dec 20;409(1):14. doi: 10.1007/s00423-023-03192-w.
7
External validation of fistula risk scores for postoperative pancreatic fistula after distal pancreatectomy.远端胰腺切除术后胰瘘术后瘘风险评分的外部验证。
Surgery. 2023 Dec;174(6):1416-1421. doi: 10.1016/j.surg.2023.09.007. Epub 2023 Oct 10.
8
Imputation and missing indicators for handling missing data in the development and deployment of clinical prediction models: A simulation study.处理临床预测模型开发和部署中缺失数据的插补和缺失指标:一项模拟研究。
Stat Methods Med Res. 2023 Aug;32(8):1461-1477. doi: 10.1177/09622802231165001. Epub 2023 Apr 27.
9
Prediction of postoperative pancreatic fistula and pancreatitis after pancreatoduodenectomy or distal pancreatectomy: A review.胰十二指肠切除术或胰体尾切除术术后胰瘘和胰腺炎的预测:综述。
Scand J Surg. 2023 Jun;112(2):126-134. doi: 10.1177/14574969231167781. Epub 2023 Apr 21.
10
Development and external validation of DISPAIR fistula risk score for clinically relevant postoperative pancreatic fistula risk after distal pancreatectomy.发展和外部验证 DISPAIR 瘘管风险评分用于预测远端胰腺切除术后临床相关术后胰瘘风险。
Br J Surg. 2022 Oct 14;109(11):1131-1139. doi: 10.1093/bjs/znac266.